Página 3 - Melhores Tumores neuroendócrinos pancreáticos médicos - TOP-83 médicos

O Prof. Köstler é uma autoridade internacionalmente reconhecida em oncologia de precisão, com foco em terapias oncológicas direcionadas e imunoterapia na Wiener Privatklinik.

• Mais de duas décadas de experiência em medicina interna e oncologia
• Antigo vice-chefe de oncologia da Universidade Médica de Viena
• Especialização em cancro da mama, neoplasias ginecológicas e tumores sólidos
• Foco no desenvolvimento de biomarcadores e terapia oncológica sistémica individualizada

A Dra. Inna Ospovat é uma especialista líder em PRRT com Lutécio-177, pioneira mundial nesta terapia inovadora.

• Chefiar o departamento de terapia nuclear no Ichilov – um dos poucos centros que oferece este tratamento
• Especializar-se em oncologia e radioterapia no Hospital Universitário Hadassah
• Membro da ASTRO e da Sociedade de Oncologia Clínica de Israel
• Especialista em tratamentos radiobiológicos para tumores gastrointestinais

Um dos melhores cirurgiões de Whipple em Israel, o Dr. Klauzner chefia o Departamento de Cirurgia do Sourasky Medical Center.

• Mais de 45 anos de experiência cirúrgica
• Especializar-se em procedimentos colorretais e pancreáticos complexos
• Vasta experiência em cirurgia de cancro gastrointestinal
• Liderar uma equipa cirúrgica de topo num grande hospital de Tel Aviv

O Professor Associado Tahsin Ozatli é especialista em cancros da mama, do pulmão e gastrointestinais no Hospital Universitário Istinye Liv.

• Mais de 10 anos de experiência em oncologia
• Trabalhar na Clínica de Oncologia de Ancara e no Hospital Regional de Formação e Investigação de Erzurum
• Promovido a Professor Associado em 2016
• Estudar medicina na Universidade de Selcuk

A Dra. Ayala Hubert é chefe do Centro de Cancro Gastrointestinal do Hadassah Medical Center – especializada em cancros do sistema digestivo.

• 33 anos de experiência como oncologista médica e radioterapeuta
• Formação em psicologia na Universidade Hebraica – confere um toque humano aos cuidados oncológicos
• Certificada pela ordem tanto em Oncologia como em Radioterapia
• Membro ativo do Comité de Israel para o Cancro Gastrointestinal

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

O Professor Gul Alco é especialista em radioterapia oncológica com mais de duas décadas de experiência, atuando atualmente na Universidade Medipol de Istambul.

• Professor de Radioterapia Oncológica desde 2021
• Residência concluída na Universidade Kadir Has
• Vasta experiência no tratamento de tumores neuroendócrinos pancreáticos
• Especialização em técnicas avançadas de radioterapia

O Dr. Muzaffer Al é especializado em cirurgia laparoscópica para tumores neuroendócrinos pancreáticos nos Hospitais Büyük Anadolu.

• Ser treinado em cirurgia laparoscópica avançada e oncológica na Universidade de Istambul
• Ser especializado em cirurgia laparoscópica de antirrefluxo
• Ser experiente em cirurgia bariátrica laparoscópica

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Especializada em viroterapia – um campo de vanguarda da imunologia – a Dra. Jaunalksne traz mais de 30 anos de experiência ao tratamento de tumores neuroendócrinos pancreáticos.

• Chefe do Centro de Imunologia Clínica do Hospital Universitário Clínico Pauls Stradiņš
• Graduada pelo Instituto Médico de Riga com internato em Medicina Interna
• Focar na integração de abordagens de imunoterapia para melhores resultados

Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.

He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.

His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

O Dr. Alemdar é especialista em tumores neuroendócrinos pancreáticos no Complexo Hospitalar Medical Park Antalya, com ampla formação em oncologia médica.

• Ser certificado em oncologia médica desde 2018
• Ter mais de 15 anos de experiência em medicina interna e oncologia
• Formar-se na Universidade de Akdeniz, uma importante instituição médica
• Trabalhar num hospital credenciado pela JCI com unidades de oncologia avançadas

O Prof. Associado Nail Paksoy é especializado em tumores neuroendócrinos pancreáticos, com certificação da ESMO e vasta investigação em oncologia.

• Especialização em Oncologia Médica no Instituto de Oncologia da Universidade de Istambul
• Investigação publicada sobre estratégias de tratamento para tumores neuroendócrinos
• Participação em ensaios clínicos focados em terapias oncológicas avançadas
• Cargo académico na Universidade Medipol de Istambul

O Dr. Volkan Kinas é especializado em cirurgia pancreática, com foco em tumores neuroendócrinos nos Hospitais Büyük Anadolu.

• Especializar-se em cirurgia pancreática e oncológica
• Lidar com casos complexos envolvendo câncer de ducto biliar e gástrico
• Ter experiência em cirurgias metabólicas bariátricas
• Trabalhar em uma equipe multidisciplinar para um atendimento abrangente

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.